| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| 2-Arachidonyl glycerol ether |
NOLADIN ETHER |
222723-55-9 |
詳細
|
| 1-(imidazo[1,2-a]pyridin-2-ylmethyl)-1H-pyrazol-3-amine |
1-(咪唑并[1,2-A]吡啶-2-基甲基)-1H-吡唑-3-胺 |
1179056-26-8 |
詳細
|
| N-(3-Hydroxyoctanoyl)-DL-homoserine lactone |
N-(3-HYDROXYOCTANOYL)-DL-HOMOSERINE LACTONE |
853799-77-6 |
詳細
|
| GLUT inhibitor-1 |
GLUT抑制劑1 |
2421141-40-2 |
詳細
|
| SP-13786 |
(S)-N-[2-(2-氰基-4,4-二氟-1-吡咯烷基)-2-氧代乙基]喹啉-4-甲酰胺 |
1448440-52-5 |
詳細
|
| Bavisant |
BAVISANT |
929622-08-2 |
詳細
|
| Specific PXR antagonist 70 |
化合物SPA70 |
931314-31-7 |
詳細
|
| 1353546-86-7 |
IBI353 |
1353546-86-7 |
詳細
|
| 3BrB-PP1 |
3-BrB-PP1 |
956025-99-3 |
詳細
|
| PR antagonist 1 |
化合物T60056 |
936345-34-5 |
詳細
|
| PF-03654764 |
化合物 PF-03654764 |
935840-35-0 |
詳細
|
| TYA-018 |
N-(3-氯苯基)-N-((5-(5-(二氟甲基)-1,3,4-惡二唑-2-基)噻唑-2-基)甲基)乙磺酰胺 |
2653254-31-8 |
詳細
|
| DiR/Cy7/18 |
DIR'[DIIC18(7) |
100068-60-8 |
詳細
|
| M2698 |
M2698 |
1379545-95-5 |
詳細
|
| X5050 |
|
2404756-81-4 |
詳細
|
| Salvigenin |
三裂鼠尾草素 |
19103-54-9 |
詳細
|
| BLU-222 |
BLU-222 |
2888704-84-3 |
詳細
|
| PT-179 |
PT-179 |
2924858-25-1 |
詳細
|
| AA-115 (APG-115) |
化合物 T14303 |
1818393-16-6 |
詳細
|
| hydrazinecarbothioic acid O-methyl ester |
O-甲基硫代硫代硫酸酯 |
19692-07-0 |
詳細
|
| Glesatinib/MGCD265 |
Glesatinib |
936694-12-1 |
詳細
|
| UNC7700 |
|
|
詳細
|
| BSJ-05-037 |
|
|
詳細
|
| Kuraridine |
次苦參素 |
34981-25-4 |
詳細
|
| Sophoflavescenol |
槐黃醇 |
216450-65-6 |
詳細
|
| GSK3395879 |
GSK3395879 |
2215852-91-6 |
詳細
|
| VX |
4-((2R,3S,4S,5R)-3-(3,4-二氟-2-羥基苯基)-4,5-二甲基-5-(三氟甲基)四氫呋喃-2-甲酰胺基)吡啶酰胺 |
2649467-91-2 |
詳細
|
| BAY-593 |
BAY-593 |
2413020-56-9 |
詳細
|
| β-AMyrenonolacetate |
Β-AMYRENONOL ACETATE |
5356-56-9 |
詳細
|
| GLXC-27578 |
|
|
詳細
|
| Tos-Lys-OMe·HCl |
TOS-L-賴氨酸甲酯鹽酸鹽 |
5266-48-8 |
詳細
|
| ESI-09 |
ESI-09 |
263707-16-0 |
詳細
|
| (R)-N1-(2-Methoxyethyl)-N1,5-dimethylhexane-1,4-diaminehydrochloride |
(R)-N1-(2-甲氧基乙基)-N1,5-二甲基己烷-1,4-二胺鹽酸鹽 |
2654084-02-1 |
詳細
|
| Olean-12-ene-3,11-dione |
OLEAN-12-ENE-3,11-DIONE |
2935-32-2 |
詳細
|
| β-Amyrenonol |
Β-香樹脂酮醇 |
38242-02-3 |
詳細
|
| AU-24118 |
|
|
詳細
|
| 2861227-35-0 |
|
2861227-35-0 |
詳細
|
| MONLUNABANT |
MONLUNABANT |
2712480-46-9 |
詳細
|
| SKF81297 |
SKF-81297氫溴酸鹽 |
71636-61-8 |
詳細
|
| OF-Deg-Lin |
化合物 OF-DEG-LIN |
1853202-95-5 |
詳細
|
| 396728-08-8 |
|
396728-08-8 |
詳細
|
| ProductEnglishName:(S)-N-(2-(2-Methoxyphenyl)-2-((2-oxo-1,2-dihydroquinoline)-6-sulfonamido)acetyl)-N-(thiophen-2-ylmethyl)glycine |
|
2411972-53-5 |
詳細
|
| UniPR1331 |
UniPR1331 |
1809170-59-9 |
詳細
|
| Senaparib |
Senaparib |
1401682-78-7 |
詳細
|
| FD-1080 |
FD-1080 |
1151666-58-8 |
詳細
|
| Heptamethinecyaninedye-1 |
1H-苯并[E]吲哚鎓,2-[2-[2-氯-3-[2-(3-乙基-1,3-二氫-1,1-二甲基-2H-苯并[E]亞基)亞乙基]-1-環(huán)己烯-1-基]乙烯基]-3-乙基1,1-二甲基碘化物 |
162411-29-2 |
詳細
|
| 1799316-56-6 |
|
1799316-56-6 |
詳細
|
| CCDLipid01 |
LP-01 |
1799316-64-5 |
詳細
|
| 1220890-35-4 |
|
1220890-35-4 |
詳細
|
| AbacavirEPImpB |
阿巴卡韋相關(guān)物質(zhì)D |
1443421-69-9 |
詳細
|
| RMC-3943 |
RMC-3943 |
1801764-60-2 |
詳細
|
| 883548-84-2 |
|
883548-84-2 |
詳細
|
| CT1812 |
CT1812 |
1802632-22-9 |
詳細
|
| 2656397-14-5 |
|
2656397-14-5 |
詳細
|
| C14-4(C14-494,LipidB-4,LipidB4) |
1,1′-[[2-[2-[4-[2-[[2-[2-[雙(2-羥基十四烷基)氨基]乙氧基]乙基](2-羥基十四烷基)氨基]乙基]-1-哌嗪基]乙氧基]乙基]亞氨基]雙[2-十四烷醇 |
2639634-80-1 |
詳細
|
| 2815425-76-2 |
|
2815425-76-2 |
詳細
|
| DN02 |
化合物 DN02 |
|
詳細
|
| PSNCBAM-1 |
1-(4-氯苯基)-3-[3-[6-(吡咯烷-1-基)吡啶-2-基]苯基]脲 |
877202-74-9 |
詳細
|
| Tolebrutinib/SAR442168/PRN2246 |
(R)-1-(1-丙烯酰哌啶-3-基)-4-氨基-3-(4-苯氧基苯基)-1H-咪唑并[4,5-C]吡啶-2(3H)-酮 |
1971920-73-6 |
詳細
|
| 216793-38-0 |
|
216793-38-0 |
詳細
|
| CFI-402257 hydrochloride |
CFI-402257 HCl |
1610677-37-6 |
詳細
|
| JNJ-40355003 |
JNJ 40355003 |
1394894-41-7 |
詳細
|
| PalbociclibImpurity2 |
帕博西尼雜質(zhì)G |
2204863-06-7 |
詳細
|
| PalbociclibImpurityN-Oxide |
Palbociclib Impurity N-Oxide |
2174002-29-8 |
詳細
|
| Abacavirimpurity3 |
阿巴卡韋雜質(zhì)F |
1443421-68-8 |
詳細
|
| ent-Abacavir |
醋丁洛爾雜質(zhì)I |
136470-79-6 |
詳細
|
| GBD-9 |
|
2864408-92-2 |
詳細
|
| JNJ-64264681 |
化合物 JNJ-64264681 |
2101524-34-7 |
詳細
|
| DobutaMinehydrochloride |
多巴酚丁胺 |
34368-04-2 |
詳細
|
| PF-06821497 |
PF-06821497 |
1844849-10-0 |
詳細
|
| tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu |
索瑪魯肽側(cè)鏈 |
1118767-16-0 |
詳細
|
| IDOR-1117-2520 |
化合物 IDOR-1117-2520 |
2737274-49-4 |
詳細
|
| ent-Efavirenz |
(R)-依法韋侖 |
154801-74-8 |
詳細
|
| EverolimusImpurity15 |
依維莫司EP雜質(zhì)E |
1237826-25-3 |
詳細
|
| (4R)-5-(3',4'-Dihydroxyphenyl)-γ-valerolactone ((-)-Epicatechin Metabolite) |
2(3H)-Furanone,5-[(3,4-dihydroxyphenyl)methyl]dihydro-,(5R)-(9CI) |
191666-22-5 |
詳細
|
| Orforglipronhemicalciumhydrate |
|
3008544-96-2 |
詳細
|
| TAK-994 |
N-((2S,3S)-1-(2-羥基-2-甲基丙?；?-2-((2,3',5'-三氟-[1,1'-聯(lián)苯]-3-基)甲基)吡咯烷-3-基)甲磺酰胺 |
2274802-95-6 |
詳細
|
| Tunlametinib |
4-氟-5-[(2-氟-4-碘苯基)氨基]-N-(2-羥基乙氧基)-6-苯并噻唑酰胺 |
1801756-06-8 |
詳細
|
| ACT-1016-0707 |
|
2569467-78-1 |
詳細
|
| CR-1-31-B |
CR-1-31-B |
1352914-52-3 |
詳細
|
| 1207280-24-7 |
|
1207280-24-7 |
詳細
|
| Tert-Butyl-d9-Amine |
叔丁胺-D9 |
6045-08-5 |
詳細
|
| AMG-193 |
AMG193 |
2790567-82-5 |
詳細
|
| PalbociclibImpurity112 |
帕布昔利布53 |
1974279-20-3 |
詳細
|
| NFX-179/Nedometinib |
化合物NEDOMETINIB |
2252314-46-6 |
詳細
|
| NPD4928 |
NPD4928 |
956965-61-0 |
詳細
|
| RMC-4627 |
|
2250059-52-8 |
詳細
|
| diABZISTINGagonist-1 |
DIABZI STING AGONIST-1 |
2138299-33-7 |
詳細
|
| 5ALPHA-CYPRINOLSULFATE |
|
15066-41-8 |
詳細
|
| SAGE-718 |
化合物 DALZANEMDOR |
1629853-48-0 |
詳細
|
| PhosTAC7 |
化合物 PHOSTAC7 |
3016307-75-5 |
詳細
|
| 2-(4-HYDROXY-3,5-DIMETHYLPHENYL)-5,7-DIMETHOXYQUINAZOLIN-4(3H)-ONE |
2-(4-HYDROXY-3,5-DIMETHYLPHENYL)-5,7-DIMETHOXYQUINAZOLIN-4(3H)-ONE |
1044870-30-5 |
詳細
|
| SMD-3040 |
|
3033109-92-8 |
詳細
|
| NT-0249 |
NT-0249 |
2763617-39-4 |
詳細
|
| Lagociclovir |
2',3'-二脫氧-3'-氟鳥苷 |
92562-88-4 |
詳細
|
| Chitin synthase inhibitor 4 |
化合物 CHITIN SYNTHASE INHIBITOR 4 |
2755847-31-3 |
詳細
|
| RMC-4529 |
|
2250059-27-7 |
詳細
|
| KetanserinTartrate |
|
2644662-83-7 |
詳細
|
| WD6305 |
|
|
詳細
|
| TX2-121-1 |
化合物 T29024 |
1603845-42-6 |
詳細
|